Use of innovation payments to encourage the adoption of new medical technologies in the English NHS

C. Sorenson; M.F. Drummond; G. Wilkinson

doi:10.1016/j.hlpt.2013.05.001

Use of innovation payments to encourage the adoption of new medical technologies in the English NHS

C. Sorenson, M.F. Drummond, G. Wilkinson

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: This study aimed to investigate the use of innovation payments in the English NHS.
Methods: A structured on-line survey was developed to explore the use of innovation
payments. The survey was disseminated to NHS hospital finance managers.A total of 20
surveys (n=20) were returned.
Results: The majority (70%) of responding hospitals have applied for innovation payments. In
one-third of cases, the payment was for medical devices, followed by drugs (31%), diagnostics
(19%), and other technologies (15%). Innovation payments were generally requested because
the existing HRG tariff did not reflect the cost of the technology. Processes for determining the
payment varied across hospitals, with rates based on supporting evidence of the technology's
benefits most common. While a good concept in principle, only about one-third of respondents
believed innovation payments were effective in meeting their aims in practice.
Conclusions: Improvements to the current approach to innovation payments are needed.

Original language	English
Pages (from-to)	168-173
Journal	Health Policy and Technology
Volume	2
Issue number	3
DOIs	https://doi.org/10.1016/j.hlpt.2013.05.001
Publication status	Published - Sept 2013

Keywords

Medical technology
Reimbursement
Financing
Innovation

Access to Document

10.1016/j.hlpt.2013.05.001

http://www.healthpolicyandtechnology.org/article/S2211-8837(13)00036-1/abstract

Cite this

@article{83e040509a5f4e8496ba2874689e98e7,

title = "Use of innovation payments to encourage the adoption of new medical technologies in the English NHS",

abstract = "Objectives: This study aimed to investigate the use of innovation payments in the English NHS. Methods: A structured on-line survey was developed to explore the use of innovation payments. The survey was disseminated to NHS hospital finance managers.A total of 20 surveys (n=20) were returned. Results: The majority (70%) of responding hospitals have applied for innovation payments. In one-third of cases, the payment was for medical devices, followed by drugs (31%), diagnostics (19%), and other technologies (15%). Innovation payments were generally requested because the existing HRG tariff did not reflect the cost of the technology. Processes for determining the payment varied across hospitals, with rates based on supporting evidence of the technology's benefits most common. While a good concept in principle, only about one-third of respondents believed innovation payments were effective in meeting their aims in practice. Conclusions: Improvements to the current approach to innovation payments are needed.",

keywords = "Medical technology, Reimbursement, Financing, Innovation",

author = "C. Sorenson and M.F. Drummond and G. Wilkinson",

year = "2013",

month = sep,

doi = "10.1016/j.hlpt.2013.05.001",

language = "English",

volume = "2",

pages = "168--173",

journal = "Health Policy and Technology",

issn = "2211-8837",

publisher = "Fellowship of Postgraduate Medicine",

number = "3",

}

TY - JOUR

T1 - Use of innovation payments to encourage the adoption of new medical technologies in the English NHS

AU - Sorenson, C.

AU - Drummond, M.F.

AU - Wilkinson, G.

PY - 2013/9

Y1 - 2013/9

N2 - Objectives: This study aimed to investigate the use of innovation payments in the English NHS. Methods: A structured on-line survey was developed to explore the use of innovation payments. The survey was disseminated to NHS hospital finance managers.A total of 20 surveys (n=20) were returned. Results: The majority (70%) of responding hospitals have applied for innovation payments. In one-third of cases, the payment was for medical devices, followed by drugs (31%), diagnostics (19%), and other technologies (15%). Innovation payments were generally requested because the existing HRG tariff did not reflect the cost of the technology. Processes for determining the payment varied across hospitals, with rates based on supporting evidence of the technology's benefits most common. While a good concept in principle, only about one-third of respondents believed innovation payments were effective in meeting their aims in practice. Conclusions: Improvements to the current approach to innovation payments are needed.

AB - Objectives: This study aimed to investigate the use of innovation payments in the English NHS. Methods: A structured on-line survey was developed to explore the use of innovation payments. The survey was disseminated to NHS hospital finance managers.A total of 20 surveys (n=20) were returned. Results: The majority (70%) of responding hospitals have applied for innovation payments. In one-third of cases, the payment was for medical devices, followed by drugs (31%), diagnostics (19%), and other technologies (15%). Innovation payments were generally requested because the existing HRG tariff did not reflect the cost of the technology. Processes for determining the payment varied across hospitals, with rates based on supporting evidence of the technology's benefits most common. While a good concept in principle, only about one-third of respondents believed innovation payments were effective in meeting their aims in practice. Conclusions: Improvements to the current approach to innovation payments are needed.

KW - Medical technology

KW - Reimbursement

KW - Financing

KW - Innovation

U2 - 10.1016/j.hlpt.2013.05.001

DO - 10.1016/j.hlpt.2013.05.001

M3 - Article

SN - 2211-8837

VL - 2

SP - 168

EP - 173

JO - Health Policy and Technology

JF - Health Policy and Technology

IS - 3

ER -